Loading comparison data...
Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare INSULIN DEGLUDEC (Tresiba) and Saxagliptin (Onglyza) — clinical data, side effects, and patient experiences.
Tresiba · Insulin
How it works
12.1 Mechanism of Action The primary activity of insulin, including TRESIBA, is regulation of glucose metabolism. Insulin and its analogs lower blood glucose by stimulating periphe...
Approved for
Onglyza · DPP-4 Inhibitor
How it works
Inhibits DPP-4 enzyme to increase incretin levels, enhancing glucose-dependent insulin secretion and suppressing glucagon.
Approved for
Estimated frequency (%) based on clinical trial data
Based on 2 Reddit discussions
INSULIN DEGLUDEC
0%
positive
2 threads
Saxagliptin
0%
positive
0 threads
2 Reddit threads analysed for INSULIN DEGLUDEC
Overall Sentiment
Mixed
Comparison Threads
0
Avg Post Score
32 upvotes
Have any other independent pharms/techs noticed a sudden drop in reimbursement rates on brand names, predominantly from Cigna plans? Of course we would always lose money on 90 day supplies, but we would at least be close to our cost, maybe losing $5-20$ on 30-days. However, in the past 48 ours I hav
Wellcare will not pay for brand name Tresiba in 2025. However, they will pay for insulin degludec (unbranded biologic version of Tresiba). Insulin deludec is of course on backorder. WellCare already denied the prior auth for name brand. Their other option on formulary insulin glargine-yfgn is also o
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
No community discussions found for Saxagliptin yet.
INSULIN DEGLUDEC is a Insulin, while Saxagliptin belongs to the DPP-4 Inhibitor class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles. INSULIN DEGLUDEC is administered via Subcutaneous, whereas Saxagliptin uses Oral. Route of administration can affect onset of action and patient adherence.
INSULIN DEGLUDEC carries 4 FDA warnings. Saxagliptin carries 3 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.